Medical technologyInvestments

London-based startup Stitch has raised £2.5 million to build the ultimate platform for retaining patients for clinical trials.

Stich says its Trialmap software improves compliance by helping patients manage their trial journey, while Trialview allows sponsors to measure each patient’s trial experience in real time.

The round was led by Connect Ventures with participation from Form Ventures, Boost Capital and angel investors.

“Patients are critical participants in clinical trials, but their experience is one of miscommunication, frustration and neglect,” said Sitar Teli, managing partner of Connect Ventures.

MedTech 50 – creators of the most innovative medical technologies in the UK for 2022

“Stitch is creating the first truly patient-centered clinical trial product.

“This allows sponsors to clearly and conveniently communicate the trial protocol; and patients to provide feedback on their experience in real time, improving patient retention and success rates.”

Jonathan Moszynski, co-founder and CEO of Stitch, added: “It’s fantastic to work with such an exceptional partner, Connect Ventures, who shares our vision of a world where every patient in every clinical trial is supported and listened to throughout their journey. » raises £2.2m to make diagnostic imaging accessible to everyone

Clinical trial management platform raises seed funding

Previous articleMurder charge against Adnan Syed, host of hit podcast Serial, dropped | US News
Next articleSainsbury’s in talks to transfer £500m store portfolio to LXi REIT | Business news